The findings identify social and functional experiences as potentially important correlates of depression among cancer survivors, but the study does not establish that these factors cause depression. The analysis was led by Philip Baiden of the University of Texas at Arlington, with colleagues from institutions including the University of Texas at Rio Grande Valley, and was published in PLOS One on October 21, 2026. The researchers analyzed data from the 2023 and 2024 Behavioral Risk Factor Surveillance System involving adult cancer survivors in the United States.

Among those included, 21.8% reported receiving a diagnosis of depressive disorder at some time in their life. In other words, slightly more than one in five participants reported a lifetime diagnosis, while the remaining participants did not report such a diagnosis. The study focused on the relationship between that self-reported history and an expanding set of demographic, socioeconomic, health, behavioral, functional and psychosocial factors.

Previous work discussed by the authors had linked functional limitations, loneliness and inadequate social or emotional support to depression among cancer survivors, but the researchers said earlier studies were generally small and often grouped these factors together. Grouping can make it difficult to determine whether the different experiences contribute distinct associations with depression. This analysis therefore examined loneliness, functional limitations and social and emotional support separately and considered their relationships with a lifetime depressive-disorder diagnosis alongside other participant characteristics.

The study did not directly measure whether depression began before or after cancer, nor did it evaluate how the severity of a participant’s depressive disorder related to any of the included factors. To analyze the data, the team constructed a series of hierarchical logistic regression models. Model 1 included sociodemographic factors, and Model 2 added socioeconomic status.

Model 3 incorporated physical health status and health behaviors, while Model 4 was the fully adjusted model and also included functional limitations, social and emotional support, and loneliness. Receiver operating characteristic curves were presented for the four models, along with the variables included at each stage of adjustment. These models estimated associations between the measured characteristics and the self-reported lifetime diagnosis; they did not test an intervention, establish a causal sequence or determine what would happen if loneliness or another factor were reduced.

Loneliness produced the largest observed association among the psychosocial and functional variables in the fully adjusted analysis. The adjusted odds ratio of 2.72 means that survivors reporting loneliness had 2.72 times the odds of reporting a lifetime depressive-disorder diagnosis than those not reporting loneliness, with the estimate obtained after accounting for the other variables in Model 4. It does not mean that 2.72 times as many survivors were depressed, nor does it mean that every lonely survivor had a diagnosis.

Functional limitations carried an adjusted odds ratio of 2.05, while lack of social and emotional support was associated with an adjusted odds ratio of 1.43. These separate estimates show which measured characteristics remained associated with the reported outcome after adjustment, rather than proving that the factors are interchangeable or that changing them would change depression risk. Health behaviors were included in the analysis alongside the psychosocial and functional measures.

Physical exercise was associated with a decreased likelihood of reporting a lifetime diagnosis of depressive disorder. The supplied study report does not give a specific adjusted effect estimate for that association, and it should not be interpreted as evidence that exercise caused fewer diagnoses. Because the research was observational and the outcome and other variables were self-reported, the finding establishes a statistical relationship rather than a causal effect.

The analysis also cannot determine whether exercise preceded the depressive-disorder diagnosis or whether other factors included in the models contributed to the observed association. The scope and size of the dataset distinguish this investigation from the smaller studies highlighted by the authors. That scale does not eliminate the constraints of observational research, however.

The result concerns cancer survivors included in the 2023 and 2024 Behavioral Risk Factor Surveillance System data and their self-reported experiences, rather than every person who has received a cancer diagnosis. The outcome was also a reported history of diagnosis, not a contemporaneous clinical assessment of current depression. Lead author Baiden said the results show that cancer survivorship involves psychological and social challenges as well as physical recovery.

“Our study of more than 70,000 US cancer survivors found that approximately one in five reported having received a depression diagnosis during their lifetime,” he said. “These findings remind us that cancer survivorship involves much more than physical recovery.” He added that, as advances in cancer treatment allow more people to survive the disease, long-term mental health and overall quality of life require greater attention. These statements frame the implications of the observed associations; the research itself did not measure treatment advances or evaluate whether any survivorship program improved mental-health outcomes.

The authors also emphasized support from relationships outside formal healthcare. “Our findings reinforce the importance of social and emotional support in the lives of cancer survivors,” Baiden said, adding that support from family members, friends and communities matters alongside care from healthcare providers. Co-author Batholomew Chireh described the loneliness association as particularly striking because it remained after accounting for demographic, socioeconomic and health-related characteristics.

Chireh said the result suggests that addressing loneliness should be a priority in efforts to improve the well-being of cancer survivors. That is an implication of the finding rather than evidence from a tested loneliness intervention, and the study did not determine whether changing social circumstances alters the likelihood of a depression diagnosis. Co-author Judith S. Anagbonu said the results point to an opportunity for healthcare providers to assess loneliness, emotional support and functional limitations during cancer-survivorship care.

She said routine assessments could help identify survivors who may benefit from additional mental-health services and suggested that psychosocial screening, counseling, rehabilitation and community-based support could be integrated into follow-up care where appropriate. None of these services was tested in the analysis, so the study cannot establish that such a program would prevent or treat depression. Taken together, the results offer a large-sample view of factors associated with a reported lifetime depressive-disorder diagnosis among US cancer survivors: loneliness had the strongest measured relationship, functional limitations and insufficient social or emotional support were also associated with the outcome, and physical exercise was associated with a lower likelihood of reporting the diagnosis.

The central conclusion is one of association. Loneliness stood out even in the most fully adjusted model, but the observational evidence cannot establish causation, clarify the timing of depression relative to cancer, or show that interventions targeting these factors would change mental-health outcomes.

Subject of Research: Associations of loneliness, functional limitations and social support with lifetime depression diagnosis among US cancer survivors

Article Title: Modifiable psychosocial factors linked to depression among US cancer survivors

Article References: Modifiable psychosocial factors linked to depression among US cancer survivors. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: cancer survivors, loneliness, depression, mental health, psychosocial factors, functional limitations, social support, BRFSS, United States, Modifiable, psychosocial, factors

He praises the investigators for restricting their analysis to lifetime nonsmokers of tobacco while identifying two central weaknesses: chronic bronchitis was included in the definition of COPD, and asthma was not necessarily confirmed through objective testing. Restricting the study population to people who had never smoked tobacco was, in Tashkin’s view, an important design choice. Tobacco is a major risk factor for COPD and an important contributor to asthma morbidity, so including people with a history of tobacco use would have complicated efforts to distinguish a possible cannabis association from the effects of concomitant smoking.

The letter also notes that the investigators included very large numbers of recent cannabis users in the BRFSS survey. This restriction addressed one important source of confounding, but it did not resolve the problems created by how respiratory conditions were identified in the available data. The first concern involves the study’s definition of COPD.

Chronic bronchitis is not synonymous with COPD, the letter states, because COPD requires objective confirmation of airflow obstruction that is not fully reversible. The relevant spirometric criterion is a post-bronchodilator ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) below 0.70. By contrast, chronic bronchitis is identified by symptoms such as chronic cough and sputum.

Those symptoms are common among cannabis smokers who do not have COPD. Including chronic bronchitis within the study’s COPD definition could therefore produce an apparent association between cannabis use and COPD even among people who do not have objectively confirmed airflow obstruction. A similar issue applies to the asthma analysis.

The letter observes that asthma is often diagnosed on the basis of symptoms, including frequent wheezing and cough, without objective confirmation through spirometric evidence of reversible bronchospasm or evidence of bronchospasm provoked by bronchial challenge. If the survey-based classification cannot distinguish cannabis-associated respiratory symptoms from symptoms used to diagnose asthma, the reported association between cannabis use and asthma may partly reflect symptom overlap rather than confirmed disease. The absence of self-reported spirometry findings in the BRFSS telephone survey is therefore relevant to how both findings should be understood.

This critique does not establish that inhaled cannabis has no relationship to asthma or COPD, nor does the letter report new clinical outcomes. Instead, it focuses on measurement in a cross-sectional survey of self-reported information. The source study was large and its restriction to lifetime tobacco nonsmokers strengthened its attempt to address tobacco-related confounding, but the inclusion of chronic bronchitis in the COPD definition and the reliance on symptoms without objective respiratory testing limit the conclusions that can be drawn.

The letter’s central position is that the survey’s reported associations should not be treated as equivalent to diagnoses confirmed by physiological testing. A respondent with cough, sputum or wheezing may report symptoms that resemble chronic bronchitis or asthma without meeting the accepted clinical criteria for either condition, making cautious interpretation essential to the study’s scientific meaning.

Subject of Research: Interpretation of survey associations among inhaled cannabis users, asthma and COPD

Article Title: Inhaled Cannabis, Asthma, and Chronic Obstructive Pulmonary Disease: a Population-Based Cross-Sectional Study of n = 379,049: Letter to the Editor

Article References: Tashkin, D. P. (2026). Inhaled Cannabis, Asthma, and Chronic Obstructive Pulmonary Disease: a Population-Based Cross-Sectional Study of n = 379,049: Letter to the Editor. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10745-4

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10745-4

Keywords: inhaled cannabis, asthma, COPD, chronic bronchitis, respiratory symptoms, airflow obstruction, spirometry, BRFSS, cross-sectional study, research methods, Inhaled, Cannabis

The study, published in the journal Supportive Care in Cancer, drew on the Behavioral Risk Factor Surveillance System, or BRFSS, an enormous annual health survey coordinated by the Centers for Disease Control and Prevention. Researchers led by Jeanne M. Ward of the Indiana University School of Nursing, together with John R. Blosnich of the University of Southern California and Victoria Champion of Indiana University, pooled responses from 2022 and 2023 across 24 states and territories that administered the CDC’s optional caregiving module. The resulting sample was strikingly large: nearly 200,000 adults, including 157,539 people who reported no caregiving duties, 39,047 informal caregivers looking after someone with a condition other than cancer, and 3,078 informal caregivers of cancer patients.

The investigators asked two related questions. First, how often had respondents experienced poor mental health, defined as stress, depression, or problems with emotions, during the previous 30 days? Anyone reporting six or more bad mental health days in a month was classified as experiencing frequent mental distress, a validated threshold that has been shown to track closely with clinical measures of psychological suffering such as the Kessler 6 scale. Second, had a doctor ever told the respondent they had a depressive disorder, including major depression, dysthymia, or minor depression? The first outcome captures current, situational anguish; the second captures a historical clinical diagnosis.

Because caregivers differ from non-caregivers in many ways that could confound any simple comparison, the researchers built statistical models that adjusted for a long list of covariates: age, sex, race and ethnicity, marital status, education, employment, urban versus rural residence, U.S. region, survey year, whether the respondent had exercised in the past month, and whether they reported 14 or more days of poor physical health in the previous 30 days. Logistic regression then estimated the odds of each mental health outcome associated with each type of caregiver status, holding everything else constant.

The headline finding was unambiguous. After adjustment, informal cancer caregivers had 89 percent higher odds of frequent mental distress than non-caregivers, with an adjusted odds ratio of 1.89 and a 95 percent confidence interval of 1.58 to 2.26. Non-cancer caregivers also fared worse than non-caregivers, with 58 percent higher odds of frequent mental distress. When the researchers turned to lifetime depression diagnosis, the pattern shifted: non-cancer caregivers showed the stronger signal, with 44 percent higher odds of ever being diagnosed with a depressive disorder, while cancer caregivers showed 34 percent higher odds. In other words, cancer caregiving was more strongly linked to recent, ongoing distress, whereas non-cancer caregiving was more strongly linked to a lifetime history of diagnosed depression.

That asymmetry is the most scientifically intriguing part of the study. Frequent mental distress reflects how someone has felt in the last month; a lifetime depression diagnosis reflects something that may have happened decades ago. The authors suggest several possible explanations. The ongoing, situational stress of cancer caregiving, which often intensifies as a patient’s condition deteriorates, may be generating acute distress that has not yet crystallized into a formal diagnosis. Alternatively, cancer caregivers may face barriers to accessing mental health care, or their depression may go underdiagnosed because clinical attention is understandably focused on the patient. The data cannot distinguish between these possibilities, but the pattern is consistent with the Cancer Family Caregiving Experience Model, a conceptual framework that treats caregiving as a dynamic stress process in which primary stressors such as escalating care demands and secondary stressors such as financial strain and employment disruption accumulate over the trajectory of the illness.

The unadjusted comparisons painted a vivid sociodemographic portrait of who becomes a cancer caregiver. Compared with the general population, informal cancer caregivers were significantly more likely to be female, non-Hispanic White, aged 65 or older, married or partnered, college-educated, unemployed or out of the workforce, and living in rural areas. Most of these associations were weak to moderate in effect size, but the age difference was the strongest, with a Cramér’s V of 0.17. Cancer caregivers were also significantly more likely to report frequent mental distress even before any statistical adjustment. Non-cancer caregivers, by contrast, were more likely to report 14 or more poor physical health days per month and a lifetime depression diagnosis, hinting that the caregiving relationship can run in both directions: poor health may sometimes precede and even motivate the caregiving role.

The regression models also surfaced broader correlates of psychological suffering that extend well beyond caregiving. Women had 60 percent higher odds of frequent mental distress and roughly double the odds of a lifetime depression diagnosis compared with men. Reporting 14 or more poor physical health days was the single strongest predictor in the models, associated with nearly fivefold higher odds of frequent mental distress and nearly threefold higher odds of a depression diagnosis. Lack of exercise in the previous month was linked to modestly higher odds of both outcomes. Interestingly, people living in rural areas had lower odds of both frequent mental distress and depression diagnosis than urban residents, and respondents in the Northeast reported better mental health than those in the West, findings that the authors note warrant further investigation given regional differences in health care access and reporting.

The scale of the issue is set to grow. There are approximately 2.8 million informal caregivers of cancer patients in the United States, and that number is expected to rise alongside the more than two million new cancer diagnoses projected for 2026. Informal caregivers demonstrably improve patient outcomes, bolstering patients’ mental health and helping them cope with the adverse effects of treatment, yet their own psychological needs frequently go unmet. Prior studies have hinted that cancer caregivers’ mental health needs exceed those of the general population, but rigorous population-level comparisons have been scarce, and the field has lacked recent estimates, particularly after the disruptions of the COVID-19 pandemic. A related analysis of BRFSS data from 2015–2016 through 2021–2022 found that frequent mental distress has been rising among both caregivers and the population as a whole, a broader societal trend that forms the backdrop against which this new study should be read.

The authors are careful about the limits of their evidence. BRFSS relies on self-report, introducing recall and social desirability bias, and the survey’s mental distress measure is not specific to caregiving. The data are cross-sectional, so causation cannot be established; it is possible that people with pre-existing vulnerability to distress are more likely to take on caregiving roles. Not all states administered the caregiving module, some states had response rates as low as 31 percent, and the survey did not capture cancer type, stage, or caregiving intensity, all of which are known to shape caregiver burden. The depression question also lumps together minor and major depressive conditions. Still, the persistence of the disparities after extensive adjustment strengthens the case that informal caregiving itself contributes to psychological strain, and the authors call for future research on caregiving intensity, cancer type, and stress trajectories over time.

The practical implications are concrete. The researchers argue that oncology teams, along with palliative and hospice care services, should integrate mental health screening into routine patient visits, using the patient encounter as a doorway to reach the caregiver sitting in the waiting room. Interventions should target the full stress process: reducing primary stressors such as care demands, addressing secondary stressors like financial and scheduling challenges, and supporting caregivers’ coping and self-care. Anticipatory guidance, particularly as a patient’s condition worsens or approaches end of life, could help caregivers prepare for the emotional terrain ahead. With nearly 200,000 survey responses behind these numbers, the message to clinicians and policymakers is difficult to ignore: the people holding up the cancer care system need care themselves, and the moment to notice them is now, while their distress is still measured in days rather than diagnoses.

Subject of Research: Mental health outcomes of informal cancer caregivers compared with non-cancer caregivers and non-caregivers using BRFSS 2022–2023 data

Article Title: Poor mental health days and depressive disorders comparing non-caregivers, informal non-cancer caregivers, and informal caregivers of cancer patients: BRFSS 2022–23

Article References: Ward, J. M., Blosnich, J. R., & Champion, V. (2026). Poor mental health days and depressive disorders comparing non-caregivers, informal non-cancer caregivers, and informal caregivers of cancer patients: BRFSS 2022–23. Supportive Care in Cancer, 34(11), Article 1100. https://doi.org/10.1007/s00520-026-11337-y

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11337-y

Keywords: informal caregiving, cancer caregivers, frequent mental distress, depression, BRFSS, mental health, caregiver burden, public health, oncology, supportive care, epidemiology, health disparities

The research team, led by investigators at Guangzhou Medical University with collaborators at The Hong Kong Polytechnic University and The Chinese University of Hong Kong, analyzed data from 47,939 women aged 50 to 74, the age band in which routine mammography is most strongly recommended. Poor adherence was defined conservatively as a self-reported absence of mammography within the previous two years. Even after statistical adjustment for the many confounders that typically muddy observational research, 21.5 percent of respondents fell into the non-adherent category, and the gradient across adversity scores remained robust. This is not a marginal effect confined to a small, severely affected subgroup; it is a population-level signal that touches roughly one in five eligible women.

Adverse childhood experiences, commonly abbreviated as ACEs, encompass a range of early-life stressors including physical, emotional, and sexual abuse, emotional and physical neglect, household substance abuse, household mental illness, parental separation or divorce, and witnessing domestic violence. Decades of research have tied cumulative ACE exposure to depression, substance use, cardiovascular disease, and early mortality, but the specific pathway from childhood adversity to cancer screening behavior has remained comparatively underexplored. The new study addresses that gap directly, and its findings suggest that the long shadow of childhood trauma may extend all the way into the radiology suite, quietly shaping whether women show up for a test that can detect breast cancer at its most treatable stages.

Methodologically, the study went beyond the conventional tally of adversities. The researchers deployed logistic regression to quantify the association between ACE scores and screening non-adherence, but then turned to a more sophisticated analytical framework borrowed from statistical physics: the Ising model. Originally developed to describe interactions among magnetic spins, the Ising network approach treats each adversity type as a node in a system, with pairwise statistical dependencies as the connections between nodes. This allows researchers to map the architecture of adversity itself, revealing which experiences act as hubs that hold the network together and which are peripheral. The team then applied the NodeIdentifyR algorithm, or NIRA, to simulate what would happen if individual nodes were targeted for intervention, effectively running virtual experiments on the network before any real-world program is designed.

The network analysis produced findings with immediate practical implications. Household substance abuse emerged as the node with the highest betweenness centrality and expected influence, meaning it sat on the shortest paths connecting most other adversities and carried the greatest capacity to activate the network as a whole. In plain terms, growing up in a home where drugs or alcohol were abused appears to function as a gateway experience, statistically intertwined with nearly every other form of childhood adversity and potentially amplifying their downstream effects. Meanwhile, the simulation showed that reducing the impact of emotional abuse would yield the greatest projected decrease in a woman’s cumulative adversity load, making it the single most efficient target for intervention within this network.

Perhaps the most striking individual finding concerned sexual abuse, which showed the strongest independent association with screening non-adherence of any single ACE category. This detail matters because it suggests that certain forms of trauma may carry consequences that persist even when the broader adversity count is taken into account. Clinicians and screening program designers have long recognized that mammography can be an intimate, uncomfortable, and psychologically loaded procedure; for survivors of sexual violence, the experience of a mammogram may evoke memories and anxieties that make avoidance feel protective. The study’s results give that clinical intuition quantitative weight and argue for screening environments that are sensitive to trauma histories rather than blind to them.

The concept of trauma-informed care has gained traction across health systems in recent years, but this study provides one of the clearest quantitative rationales yet for applying it to cancer prevention. A trauma-informed mammography program might include routine, private inquiry about past abuse; the option to have a female technologist; clear narration of each step of the procedure; and explicit permission to pause or stop at any moment. It might also involve longer appointment slots, sensitivity training for staff, and follow-up protocols that treat missed appointments not as patient negligence but as a potential signal of unaddressed psychological burden. The authors’ conclusion points in exactly this direction: strategies addressing the sequelae of emotional abuse, in particular, may most effectively improve screening uptake among women with high adversity burdens.

The study’s scale and design lend it credibility, but its limitations deserve honest acknowledgment. The data are cross-sectional and self-reported, drawn from survey waves in 2020, 2022, and 2024, which means the analysis captures association rather than proven causation. ACE exposure was recalled retrospectively by adults, and recall bias, particularly among respondents with depression or other trauma-related conditions, could distort the measured relationships. Self-reported screening dates may also diverge from medical records. Because the analysis was secondary and based on publicly available, de-identified data, the authors note that institutional review board approval and additional informed consent were not required. None of these caveats erases the central signal, but they do mean that intervention trials, rather than further observational work, are the logical next step.

The public health stakes are considerable. Breast cancer remains one of the most common cancers among women worldwide, and mammography screening is among the best-evidenced tools for early detection, yet adherence rates persistently lag behind targets in many populations. If more than a fifth of eligible women in this large sample were non-adherent, and if childhood adversity meaningfully raises that risk, then screening programs that ignore trauma histories are systematically missing the women who need outreach most. The dose-response structure of the finding also implies a triage opportunity: a simple ACE questionnaire, administered in primary care, could flag patients who warrant more intensive reminder systems, patient navigation, or counseling before their next screening window closes.

What makes this research resonate beyond epidemiology is its reframing of a familiar problem. Missed mammograms are often attributed to cost, access, insurance status, or simple forgetfulness, and those factors certainly matter. But this study adds a developmental dimension that has been largely invisible in screening policy: the behavioral fingerprints of childhood adversity, laid down decades before a woman becomes eligible for mammography, may quietly govern her engagement with preventive medicine. By combining a classic dose-response analysis with network science and intervention simulation, the researchers have moved the conversation from whether adversity matters to which specific adversities matter most and where a targeted intervention would do the greatest good. That shift, from description to actionable targeting, is precisely what translational psychiatry promises, and it offers screening programs a concrete starting point: address the network at its hubs, beginning with household substance abuse and emotional abuse, and the entire structure of risk may begin to loosen.

Subject of Research: The association between cumulative adverse childhood experiences and non-adherence to mammography-based breast cancer screening among middle-aged women.

Article Title: Cumulative burden of adverse childhood experiences (ACEs) and non-adherence to breast cancer screening: A dose-response and network intervention analysis

Article References: Chen, F., Shao, J., Cai, J., Ho, Y.-S., Takemura, N., Yorke, J., Li, J., & Ye, Z. (2026). Cumulative burden of adverse childhood experiences (ACEs) and non-adherence to breast cancer screening: A dose-response and network intervention analysis. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04523-3

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04523-3

Keywords: adverse childhood experiences, breast cancer screening, mammography, dose-response, Ising model, network analysis, trauma-informed care, BRFSS, preventive care, emotional abuse, household substance abuse, health behavior

Researchers at Washington University in St. Louis, led by Kimberly J. Johnson, drew on the Behavioral Risk Factor Surveillance System, or BRFSS, a giant telephone survey run by the U.S. Centers for Disease Control and Prevention that collects health information from more than 400,000 residents each year across all fifty states, the District of Columbia, and U.S. territories. For their trend analysis, the team pooled data from 2016 through 2024, encompassing 3,968,799 respondents after imputation of missing values. For a finer-grained comparison of drinking prevalence by cancer type, they used the most recent 2022 to 2024 data from the 38 states and territories that included an optional cancer survivorship module, yielding 465,870 respondents. Because BRFSS uses complex, stratified sampling, the analysts applied survey weights and multiple imputation, then pooled estimates using established statistical rules to produce nationally representative figures.

The survey questions distinguished three patterns of consumption. Current drinking was defined as having had at least one alcoholic drink in the past 30 days. Binge drinking meant four or more drinks on a single occasion for women, or five or more for men, while heavy drinking was classified as more than seven drinks per week for women and more than fourteen for men. Cancer history came from a question asking whether a respondent had ever been told by a doctor that they had cancer, and a follow-up item identified the specific cancer type. The researchers classified head and neck, esophageal, liver, breast, and colorectal cancers as alcohol-related, following the National Cancer Institute’s categorization.

The headline finding is a story of divergence, albeit a subtle one. Among adults without a cancer history, the prevalence of current drinking declined significantly, from 53.9 percent in 2016 to 51.5 percent in 2024, an average drop of 0.28 percentage points per year. Binge drinking in this group also fell, by about 0.20 percentage points annually. Among people with a cancer history, however, current drinking was essentially flat, hovering at 45.8 percent in both 2016 and 2024, with a statistically non-significant upward drift of 0.06 percentage points per year. Binge and heavy drinking trends in survivors were similarly unremarkable. In other words, whatever forces are nudging the general population toward slightly less drinking, they do not appear to be operating among cancer survivors, who started from a lower baseline and stayed there.

That baseline gap persisted after statistical adjustment. Compared with adults never diagnosed with cancer, those with a cancer history had an adjusted prevalence of current drinking 1.01 percentage points lower and binge drinking 1.16 percentage points lower, while heavy drinking showed no significant difference. People who had survived an alcohol-related cancer, such as breast or colorectal cancer, reported current drinking at a prevalence 2.17 percentage points lower than the cancer-free population, though their binge and heavy drinking rates were not significantly different. The direction of these differences held even when the analysis was restricted to adults aged 55 and older, although the estimates were attenuated and generally lost statistical significance.

The cancer-type breakdown produced some of the study’s most intriguing results. Current drinking prevalence was significantly higher than expected among survivors of testicular cancer, melanoma, and other skin cancers, while most other cancer types showed lower prevalences, with prostate and throat or pharyngeal cancers non-significantly elevated. The most common cancer types in the dataset were breast, non-melanoma skin cancer, melanoma, and prostate cancer. Because small cell sizes limited stable estimation for binge and heavy drinking within individual cancer types, the type-specific models focused on current drinking, with sex-specific restrictions applied for reproductive cancers.

One of the most revealing analyses came from a simple sensitivity check. Because some patients reduce or stop drinking during cancer treatment, the researchers repeated their prevalence difference models excluding respondents who reported currently being in treatment. The result was striking: most of the negative prevalence differences, where survivors drank less than the cancer-free population, shifted toward zero, while some of the positive differences moved further from the null. The authors interpret this as suggesting that many individuals resume alcohol consumption once treatment ends, meaning that the apparent protective gap between survivors and others may partly reflect temporary abstinence during therapy rather than a durable lifestyle change. The cross-sectional nature of the survey data, however, prevents any conclusion that a cancer diagnosis itself causes changes in drinking behavior.

The findings arrive against a backdrop of intensifying public debate about alcohol and cancer. The scientific consensus has hardened over the past decade, with meta-analyses confirming dose-response relationships and population attributable fractions estimated at 4.4 percent for female breast cancer and as high as 31.6 percent for esophageal cancer. In 2025, the U.S. Surgeon General called for cancer warning labels on alcoholic beverages, echoing advocacy from consumer and public health groups dating back to 2019. The American Cancer Society now states flatly that it is best not to drink alcohol, and the U.S. Preventive Services Task Force recommends that adults be screened for unhealthy alcohol use. Google Trends data show a steady rise in searches connecting alcohol and cancer risk since 2004. Yet awareness remains startlingly low: in a 2024 survey, only 39.4 percent of U.S. adults knew that alcohol increases cancer risk, and earlier data suggested more than half were unaware that wine, beer, or liquor carries any such risk.

Against this context, the stability of drinking among survivors is particularly consequential. Alcohol consumption may raise the risk of second primary cancers in survivors, making continued drinking a clinically meaningful concern rather than a matter of taste alone. Prior research offers mixed signals about whether diagnosis changes behavior. A Canadian study of more than 500 survivors found that among 299 patients who drank at diagnosis, 52 percent reported reduced or no consumption one year later. A study of 973 head and neck cancer patients recorded a decline in drinking from 54.3 percent to 41.2 percent within a year of diagnosis. But a German study of 300 survivors found that 70 percent continued to drink six months after diagnosis. The new BRFSS analysis suggests that, at the population level, any such reductions are modest and may fade once treatment concludes.

The study also highlights a persistent gap in clinical practice. Although alcohol screening is recommended in oncology and primary care settings, previous research indicates that heavy drinkers with a cancer history are not consistently counseled to cut back; one study found that only 15 percent of cancer survivors consuming three or more drinks per day were advised by a provider to reduce their intake. The authors note that their results provide a contemporary baseline against which future changes can be measured, as dietary guidance and the alcohol environment evolve. They also acknowledge limitations: cancer history and alcohol use were self-reported and subject to recall and social desirability bias, some states lacked data in certain years, and small samples for some cancer types reduced precision. Survivors aware of alcohol’s risks may also under-report their drinking, potentially widening the apparent gap. Still, with nearly four million respondents, weighted analyses, and careful handling of missing data, the study stands as a sobering snapshot: as national conversation about alcohol and cancer grows louder, the drinking habits of American cancer survivors have barely moved at all.

Subject of Research: Alcohol consumption patterns and trends among U.S. adults with and without a cancer history

Article Title: Prevalence and trends in recent alcohol consumption by cancer history and cancer type in a nationally representative sample of U.S. adults

Article References: Johnson, K. J., Eyler, A. A., & Harris, J. K. (2026). Prevalence and trends in recent alcohol consumption by cancer history and cancer type in a nationally representative sample of U.S. adults. Cancer Causes & Control, 37(10), Article 167. https://doi.org/10.1007/s10552-026-02248-8

Image Credits: AI Generated

DOI: 10.1007/s10552-026-02248-8

Keywords: alcohol consumption, cancer survivors, cancer risk, BRFSS, binge drinking, heavy drinking, cancer epidemiology, public health, surgeon general, health behavior, national survey, alcohol-related cancers

Cultural racism is a concept that has long eluded precise measurement. Unlike interpersonal discrimination, which individuals can report directly, cultural racism refers to the underlying ideologies, values, images and narratives that normalize racial hierarchy: derogatory media portrayals, exclusionary cultural norms, and the everyday symbols and assumptions that render inequality seemingly natural. Researchers have argued that this cultural layer is the soil in which structural and individual racism grow, yet its health consequences have remained understudied because of the difficulty of quantifying it. The new research, led by Oyomoare L. Osazuwa-Peters of Duke University School of Medicine together with colleagues including Nancy Krieger of Harvard T.H. Chan School of Public Health and Tyson Brown of Duke University, set out to close that gap with an empirically derived measure spanning all fifty states and the District of Columbia.

To construct the exposure, the team distilled seven state-level indicators into a single composite score they call the cultural racism factor. Drawing on prior theoretical work, the indicators captured multiple dimensions of the construct, including anti-Black sentiment in attitudes, disparate representation in positions of influence and media, and resource-related dimensions reflecting how cultural priorities are encoded in state-level conditions such as income inequality measured by the Gini coefficient, poverty rates, and population characteristics derived from US Census and American Community Survey data. The factor was validated using established psychometric techniques, including confirmatory factor analysis and reliability estimation, to ensure that the composite genuinely reflected a shared underlying dimension rather than a statistical artifact. The resulting measure and its indicator values have been made publicly available through Zenodo, allowing other researchers to scrutinize and reuse the instrument.

The outcome data came from an extraordinary source: the Behavioral Risk Factor Surveillance System, the Centers for Disease Control and Prevention’s massive annual telephone survey, covering the years 2018 through 2021. After linking each respondent to the cultural racism score of their state of residence, the analytical sample comprised 1,292,787 adults, weighted to be 52.2 percent women. Within this population, 19.5 percent reported a history of depression, and respondents averaged 4.3 days of poor mental health per month. Because the survey spans the onset of the COVID-19 pandemic, the study window also captures a period of documented deterioration in American mental health, which the authors contextualized against prior evidence of rising psychological distress between 1993 and 2020.

The statistical strategy was designed for rigor in the face of complex survey data. The researchers used modified Poisson regression, an approach well suited to estimating relative risks for binary outcomes such as depression history, along with models for the count of poor mental health days. Models adjusted for a battery of individual and state-level confounders, including age, sex, race and ethnicity, income, and other state characteristics, to reduce the likelihood that the association simply reflects broader regional differences in wealth, urbanicity, or health care access. Analyses followed established guidelines for reporting observational studies, and the authors pre-specified stratified analyses to examine whether associations varied across racial and ethnic groups, age strata, and sex.

The headline result is deceptively simple in its expression but profound in its implications. Each one standard deviation increase in the state-level cultural racism factor was associated with a 3 percent higher relative risk of reporting a history of depression overall, and a 3 percent increase in the number of poor mental health days. Three percent may sound modest, but applied across an entire population and a full standard deviation of variation in cultural racism between states, it translates into a substantial population burden, particularly given that tens of millions of adults experience depression and psychological distress each year.

The stratified results revealed far starker disparities. Among Native Hawaiian and Pacific Islander respondents, each standard deviation increase in cultural racism was associated with up to a 25 percent higher risk of depression, the largest effect observed for any group. Among Hispanic respondents, the association with poor mental health days reached as high as 14 percent per standard deviation. Associations were consistently strongest among racial minority groups, the populations most directly targeted by the ideologies and systems the factor is designed to capture, and among adults under 65 years of age. Notably, the associations did not differ significantly between men and women, suggesting that the corrosive influence of cultural racism on mental health operates across gender lines rather than being concentrated in one.

These findings align with a growing body of research on racism and health. Prior studies have linked police killings of Black Americans to spillover effects on the mental health of Black communities, shown that perceived discrimination is associated with worse psychiatric outcomes in meta-analyses, and demonstrated that structural racism, expressed through historic redlining and contemporary lending patterns, leaves measurable imprints on population health. A related 2025 study by several of the same investigators showed that a latent measure of cultural racism was associated with US mortality and life expectancy, extending the health consequences of cultural racism beyond mental health into physical health and survival. The new work complements this literature by demonstrating that the cultural dimension of racism is not merely a backdrop for more tangible forms of discrimination but carries its own detectable psychological toll.

The biological and social pathways plausibly connecting cultural racism to depression are multifaceted. Chronic exposure to devaluing cultural messages can function as a persistent psychosocial stressor, activating physiological stress responses, eroding self-concept, and fostering vigilance and alienation. Stereotype threat research has shown that merely confronting negative cultural portrayals can impair cognition and decision making, while studies of media representation demonstrate lasting effects on identity and wellbeing, particularly among young people from marginalized groups. Cultural racism may also operate indirectly by legitimizing inequitable policies, shaping where resources flow, and normalizing the social conditions, such as poverty, segregation, and reduced access to care, that are themselves robust predictors of mental illness.

The authors are careful to note that their observational design cannot prove causation, and that residual confounding by unmeasured state or individual characteristics remains possible. Self-reported depression history and mental health days, while validated and widely used, are imperfect measures. Yet the sheer scale of the sample, the psychometric grounding of the exposure measure, the consistency of associations across outcomes and subgroups, and the coherence with prior evidence collectively strengthen the case that cultural racism is a genuine determinant of mental health. The study’s data, drawn from publicly available CDC survey files and open repository sources, invite replication and extension by independent teams.

The implications reach well beyond academic debate. If the cultural climate of a state measurably shapes the psychological health of its residents, then interventions aimed solely at individual-level care are addressing symptoms rather than causes. The findings underscore, in the authors’ words, the need for further research and policy action: policies that address media representation, educational narratives, income inequality, and the cultural norms that sustain racial hierarchy may be mental health interventions in their own right. As the United States continues to grapple with rising rates of depression and psychological distress, this research adds a sobering dimension to the national conversation, suggesting that the stories a society tells about race, and the systems those stories sustain, are written not only into institutions but into the minds of the millions of people who live within them.

Subject of Research: Association of state-level cultural racism with depression and poor mental health days among US adults, 2018–2021

Article Title: Association of cultural racism with mental health outcomes among US adults during 2018–2021

Article References: Osazuwa-Peters, O. L., Wilkerson, J., Gupta, A., Wilson, L. E., Krieger, N., Brown, T., & Akinyemiju, T. (2026). Association of cultural racism with mental health outcomes among US adults during 2018–2021. Nature Mental Health. https://doi.org/10.1038/s44220-026-00728-z

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00728-z

Keywords: cultural racism, mental health, depression, BRFSS, health disparities, structural racism, psychological distress, population health, racial inequities, public health, Association, cultural

The research team, led by Areesh Mevawalla and Timothy M. Pawlik of The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, drew on the 2022 Behavioral Risk Factor Surveillance System, an annual, state-based telephone survey administered by the Centers for Disease Control and Prevention. Because the Caregiver Module was administered in Georgia, Louisiana, Mississippi, New Hampshire, Ohio, Oregon, Pennsylvania, Utah, Virginia, Washington, Wisconsin, and Puerto Rico, the analysis was restricted to those jurisdictions, with CDC-provided sampling weights, strata, and primary sampling units used to generate population-representative estimates. Of the 10,923 caregivers in the analytic cohort, 1,483, or 13.6 percent, were caring for someone whose main health problem was cancer.

The outcome of interest was frequent mental distress, defined using established BRFSS methodology as fourteen or more days in the past thirty during which stress, depression, or emotional problems made mental health not good. The investigators focused on four modifiable protective factors, each selected a priori for its established relevance to psychological distress: sufficient sleep, defined as at least seven hours per night; regular physical activity outside of job duties in the past thirty days; non-smoking status; and adequate emotional support, meaning support was usually or always available. By summing these binary indicators, the team constructed a Cumulative Protective Factor Score ranging from zero to four, allowing them to test a central theoretical premise drawn from the Stress-Buffering Hypothesis, the idea that layered psychosocial and behavioral resources can blunt the corrosive mental health effects of sustained stress.

The demographic portrait of cancer caregivers differed in subtle but meaningful ways from their non-cancer counterparts. Cancer caregivers were slightly older, with a median age of fifty-nine years, and more likely to be female, at 64.3 percent versus 61.4 percent. Their caregiving was typically shorter in duration, with cancer caregivers more likely to have been providing care for one to six months or six months to under two years, whereas non-cancer caregivers more commonly reported commitments of five years or longer, reflecting the episodic but intensive nature of cancer treatment trajectories. Cancer caregivers were also more likely to be caring for a spouse or partner or a non-relative friend, while non-cancer caregivers more frequently cared for children or grandchildren.

Across every protective factor measured, cancer caregivers fared worse. They were less likely to report sufficient sleep, at 60.1 percent versus 64.5 percent; regular physical activity, at 75.8 percent versus 79.5 percent; non-smoking status, at 84.6 percent versus 89.4 percent; and adequate emotional support, at 71.9 percent versus 78.8 percent, with all differences statistically significant. Only 40.3 percent of cancer caregivers reported all four protective factors, compared with 42.2 percent of non-cancer caregivers. This pattern of depleted reserves coincided with the elevated distress: cancer caregiver status was independently associated with higher odds of frequent mental distress in survey-weighted multivariable logistic regression, with an odds ratio of 2.18.

Each individual protective factor was associated with lower odds of frequent mental distress in the full cohort. Sufficient sleep was linked to roughly a 53 percent reduction in odds, regular physical activity to a 29 percent reduction, adequate emotional support to a 65 percent reduction, and non-smoking status to a 37 percent reduction, all highly significant. However, interaction analyses revealed an important nuance: the protective associations of sleep, physical activity, and emotional support were significantly attenuated among cancer caregivers, with interaction odds ratios ranging from 0.69 to 0.76. In other words, the same behaviors appear to confer somewhat less protection in the context of cancer caregiving, perhaps because the intensity of the caregiving stressor overwhelms single resources acting alone.

The cumulative picture was far more encouraging. Using marginal standardization to estimate fully adjusted predicted probabilities, the researchers found a graded, inverse relationship between the protective factor score and frequent mental distress in both groups. Among caregivers with no protective factors, the predicted probability of distress reached 0.76 for cancer caregivers versus 0.59 for non-cancer caregivers, a substantial and statistically significant gap. That gap narrowed steadily across scores of one, two, and three. At the maximum score of four, predicted distress fell to just 10 percent among cancer caregivers and 7 percent among non-cancer caregivers, a difference that was no longer statistically significant. The co-occurrence of all four health-promoting behaviors and support resources appeared sufficient to offset the heightened psychological burden of cancer caregiving almost entirely.

The findings also exposed a persistent sex disparity that no amount of protective accumulation fully resolved. Female cancer caregivers had 40 percent higher odds of frequent mental distress than males, and predicted probabilities were higher for women at every level of the cumulative score. With no protective factors, the predicted probability of distress was 0.85 for women versus 0.68 for men; even at the maximum score of four, women faced a predicted probability of 0.17 compared with 0.08 for men, both differences highly significant. The authors point to a substantial literature suggesting that women disproportionately assume primary caregiving roles, provide more intensive and complex care, and carry additional cognitive-emotional labor, including coordinating treatment, managing family stress, and supplying emotional support to others. Prior research has found that women caring for an ill spouse were nearly six times more likely to experience depressive or anxious symptoms than non-caregiving women, while the authors caution that lower observed distress among men may reflect under-recognition and reluctance to seek support rather than genuine resilience.

The study has limitations worth noting. Its cross-sectional design precludes causal inference, leaving open the question of whether depleted health behaviors precede distress or follow from it, and all measures were self-reported, introducing potential recall and reporting bias. BRFSS also does not capture primary caregiver status, task complexity, cancer stage, or treatment phase, so some differences in distress may reflect variation in illness course. Even so, the surveillance system remains a well-validated, nationally representative instrument for population-level behavioral research, and the consistency of the graded dose-response pattern strengthens the plausibility of the cumulative buffering effect.

The implications reach well beyond individual self-care advice. The authors argue that cancer centers should routinely screen for caregiver distress as part of patient management, and they point to legislative momentum from the RAISE Family Caregivers Act and the CARE Act, which mandate expanding support services and formally assessing caregiver needs within hospital care. Evidence-backed measures such as subsidized respite care, affordable counseling, and caregiver-inclusive clinic visits have been shown to reduce burden, particularly among high-risk groups. Because women remain at elevated risk even under the most favorable behavioral profiles, and because men’s needs may go unrecognized, the researchers call for sex-responsive, caregiver-centered support models rather than one-size-fits-all programs. As the population of U.S. informal caregivers has grown from roughly 43.5 million in 2015 to nearly 53 million in 2020, the study suggests that a coordinated, multilevel response, spanning sleep promotion, physical activity, smoking cessation, emotional support, and structural policy reform, is essential to protect the mental health of those who sustain cancer care at home.

Subject of Research: Health behaviors, mental distress, and sex disparities among U.S. cancer caregivers

Article Title: Buffering the burden: health behaviors, mental distress, and sex disparities in U.S. cancer caregivers

Article References: Mevawalla, A., Sarfraz, A., Alizai, Q., Angez, M., Bega, R., Chaudhry, M. Q., Ashraf, A., Elemosho, A., Chatzipanagiotou, O. P., & Pawlik, T. M. (2026). Buffering the burden: health behaviors, mental distress, and sex disparities in U.S. cancer caregivers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02120-3

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02120-3

Keywords: cancer caregivers, frequent mental distress, health behaviors, BRFSS, sleep, physical activity, emotional support, smoking, sex disparities, caregiver burden, stress-buffering hypothesis, cancer survivorship